[go: up one dir, main page]

ZA9711565B - Vaccine - Google Patents

Vaccine

Info

Publication number
ZA9711565B
ZA9711565B ZA9711565A ZA9711565A ZA9711565B ZA 9711565 B ZA9711565 B ZA 9711565B ZA 9711565 A ZA9711565 A ZA 9711565A ZA 9711565 A ZA9711565 A ZA 9711565A ZA 9711565 B ZA9711565 B ZA 9711565B
Authority
ZA
South Africa
Prior art keywords
vaccine
Prior art date
Application number
ZA9711565A
Inventor
Jean-Francois Luci Maisonneuve
Vincent Georges Christ Verlant
Original Assignee
Smithkline Beecham Biolog
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Biolog filed Critical Smithkline Beecham Biolog
Publication of ZA9711565B publication Critical patent/ZA9711565B/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/118Chlamydiaceae, e.g. Chlamydia trachomatis or Chlamydia psittaci
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/39Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/54Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541Mucosal route
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/555Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511Organic adjuvants
    • A61K2039/55544Bacterial toxins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
ZA9711565A 1996-12-24 1997-12-23 Vaccine ZA9711565B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9626864.4A GB9626864D0 (en) 1996-12-24 1996-12-24 Vaccine

Publications (1)

Publication Number Publication Date
ZA9711565B true ZA9711565B (en) 1998-08-27

Family

ID=10805014

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9711565A ZA9711565B (en) 1996-12-24 1997-12-23 Vaccine

Country Status (9)

Country Link
EP (1) EP0948352A1 (en)
JP (1) JP2001507004A (en)
AR (1) AR011047A1 (en)
AU (1) AU5763998A (en)
CA (1) CA2275896A1 (en)
CO (1) CO4650187A1 (en)
GB (1) GB9626864D0 (en)
WO (1) WO1998028005A1 (en)
ZA (1) ZA9711565B (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1486215A3 (en) * 1997-03-21 2006-04-12 Chiron Corporation Detoxified mutants of bacterial ADP-ribosylating toxins as parenteral adjuvants
US5962636A (en) * 1998-08-12 1999-10-05 Amgen Canada Inc. Peptides capable of modulating inflammatory heart disease
US20020061848A1 (en) 2000-07-20 2002-05-23 Ajay Bhatia Compounds and methods for treatment and diagnosis of chlamydial infection
US7722887B1 (en) * 1999-09-15 2010-05-25 Mogam Biotechnology Research Institute Detoxified mutants of escherichia coli heat-labile enterotoxin
EP1812058B1 (en) * 2004-10-25 2012-06-13 Statens Serum Institut Chlamydia trachomatis antigens for vaccine and diagnostic use
KR20070121814A (en) * 2005-03-31 2007-12-27 글락소스미스클라인 바이오로지칼즈 에스.에이. Vaccines against Chlamydia Infection
US8541007B2 (en) 2005-03-31 2013-09-24 Glaxosmithkline Biologicals S.A. Vaccines against chlamydial infection
EP2576602B1 (en) 2010-05-28 2020-02-12 Spixia Biotechnology AB Chimeric momp antigen, method and use
CA2976243C (en) 2015-02-10 2023-10-31 Ohio State Innovation Foundation Chlamydia-activated b cell platforms and methods thereof
US10835601B2 (en) 2015-11-10 2020-11-17 Ohio State Innovation Foundation Methods and compositions related to accelerated humoral affinity
AR132053A1 (en) 2023-03-02 2025-05-21 Sanofi Pasteur COMPOSITIONS FOR USE IN THE TREATMENT OF CHLAMYDIA

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6019982A (en) * 1994-08-26 2000-02-01 The Administrators Of The Tulane Educational Fund Mutant enterotoxin effective as a non-toxic oral adjuvant
JPH10509325A (en) * 1994-11-17 1998-09-14 マキシム ファーマシューティカルズ,インコーポレイテッド An immunogen that stimulates mucosal immunity
GB9506863D0 (en) * 1995-04-03 1995-05-24 Smithkline Beecham Biolog Vaccines
FR2732605B1 (en) * 1995-04-07 1997-05-16 Pasteur Merieux Serums Vacc COMPOSITION FOR INDUCING MUCOSAL IMMUNE RESPONSE
CN1195297A (en) * 1995-07-07 1998-10-07 奥拉瓦克斯有限公司 Clostridium difficile toxin as a mucosal adjuvant

Also Published As

Publication number Publication date
AU5763998A (en) 1998-07-17
CA2275896A1 (en) 1998-07-02
WO1998028005A1 (en) 1998-07-02
JP2001507004A (en) 2001-05-29
EP0948352A1 (en) 1999-10-13
CO4650187A1 (en) 1998-09-03
GB9626864D0 (en) 1997-02-12
AR011047A1 (en) 2000-08-02

Similar Documents

Publication Publication Date Title
HUP9904549A3 (en) Vaccines
GB9712347D0 (en) Vaccine
GB9718901D0 (en) Vaccine
GB9727262D0 (en) Vaccine
GB9711990D0 (en) Vaccine
GB9726555D0 (en) Vaccine
GB9720585D0 (en) Vaccine
EP0958373A4 (en) Vaccines
PL331424A1 (en) Antipaludian vaccine composition
ZA979984B (en) Vaccine composition
ZA9711565B (en) Vaccine
GB9625968D0 (en) Vaccine
ZA982763B (en) Vaccines
GB9417880D0 (en) Vaccine
ZA973824B (en) Vaccines
GB9419969D0 (en) Vaccine
GB9625966D0 (en) Vaccine
GB9625967D0 (en) Vaccine
GB9604595D0 (en) Vaccines
GB9606032D0 (en) Vaccines
GB9602617D0 (en) Vaccines
GB9626882D0 (en) Vaccines
GB9604596D0 (en) Vaccines
GB9605229D0 (en) Vaccines
GB9614182D0 (en) Vaccines